This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Severe GBA1 variants drive the GBA-PD clinical phenotype: implications for counselling and clinical trials
Output Details
Description
**Background** Variants in the *GBA1* gene are the commonest genetic risk factor for Parkinson disease (PD). Genotype-phenotype correlations exist but with conflicting data, particularly in the cognitive domain.
**Objectives** Comparing clinical phenotypes in a multicentre, international cohort incorporating GBA-PD and idiopathic PD (iPD) patients.
**Methods** Patients underwent a comprehensive assessment of motor and non-motor functions. Two-group (GBA-PD vs iPD) and multiple-group comparisons (iPD, risk, mild, and severe variant GBA-PD) were performed.
**Results** Three hundred fifteen PD patients were recruited: 186 iPD, 39 severe GBA-PD, 24 mild GBA-PD, 56 risk GBA-PD, and 10 patients carrying variants of unknown significance. Groups were matched for sex, disease duration and medications. Mild and severe GBA-PD were younger and developed PD earlier. Severe GBA-PD had worse depression, cognitive impairment and hyposmia, and a trend for higher rates of motor complications.
**Conclusions** Only severe variant GBA-PD have a distinctive, more severe clinical profile.
Identifier (DOI)
10.1101/2024.12.09.24318560